HIGH-DOSE INHALED STEROID-THERAPY FOR ASTHMA

被引:57
作者
TOOGOOD, JH [1 ]
机构
[1] UNIV WESTERN ONTARIO,LONDON N6A 3K7,ONTARIO,CANADA
关键词
D O I
10.1016/0091-6749(89)90034-1
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:528 / 536
页数:9
相关论文
共 15 条
[1]  
JOHANSSON SA, 1982, EUR J RESPIR DIS, V63, P74
[2]  
NADEAU J, 1986, J ALLERGY CLIN IMMUN, V77, P150
[3]  
TOOGOOD JH, 1983, CHEST, V84, P349
[4]  
TOOGOOD JH, 1987, J ALLERGY CLIN IMMUN, V79, P144
[5]   INFLUENCE OF DOSING FREQUENCY AND SCHEDULE ON THE RESPONSE OF CHRONIC ASTHMATICS TO THE AEROSOL STEROID, BUDESONIDE [J].
TOOGOOD, JH ;
BASKERVILLE, JC ;
JENNINGS, B ;
LEFCOE, NM ;
JOHANSSON, SA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1982, 70 (04) :288-298
[6]   USE OF SPACERS TO FACILITATE INHALED CORTICOSTEROID TREATMENT OF ASTHMA [J].
TOOGOOD, JH ;
BASKERVILLE, J ;
JENNINGS, B ;
LEFCOE, NM ;
JOHANSSON, SA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1984, 129 (05) :723-729
[7]   EFFECT OF HIGH-DOSE INHALED BUDESONIDE ON CALCIUM AND PHOSPHATE-METABOLISM AND THE RISK OF OSTEOPOROSIS [J].
TOOGOOD, JH ;
CRILLY, RG ;
JONES, G ;
NADEAU, J ;
WELLS, GA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (01) :57-61
[8]  
TOOGOOD JH, 1985, ANN ALLERGY, V55, P257
[9]  
TOOGOOD JH, 1985, CLIN INVEST MED, V8, pA42
[10]  
TOOGOOD JH, 1983, LANCET, V2, P790